logo
New AI tool could speed up skin cancer diagnoses in remote parts of world

New AI tool could speed up skin cancer diagnoses in remote parts of world

Rhyl Journal5 days ago
Tess Watt, the PhD student at Heriot-Watt University in Edinburgh who led the project to develop the technology, said it is intended to enable early detection of skin conditions anywhere in the world, and without the need for direct access to dermatologists.
The technology also works without internet access.
The system involves a patient taking a photograph of their skin complaint using a small camera attached to a Raspberry Pi device – a cheap, energy-efficient handheld computer that is capable of storing vast amounts of information.
The photograph is analysed in real-time using the latest state-of-the-art image classification, comparing it to an enormous dataset of thousands of images stored on the device to reach a diagnosis.
The findings are then shared with a local GP service to begin a suitable treatment plan.
The project is understood to be the first of its kind to combine AI medical diagnosis with the aim of serving remote communities.
Ms Watt explained: 'Healthcare from home is a really important topic at the moment, especially as GP wait times continue to grow.
'If we can empower people to monitor skin conditions from their own homes using AI, we can dramatically reduce delays in diagnosis.'
A prototype of the device has already been demonstrated at Heriot-Watt's advanced health and care technologies suite.
The research team said the tool is up to 85% accurate in its diagnostic capabilities, but they hope to increase this further by gaining access to more skin lesion datasets, aided by advanced machine tools.
Ms Watt is also in talks with NHS Scotland to begin the ethical approval process for testing the technology in real-world clinical settings.
'Hopefully in the next year or two, we'll have a pilot project under way,' she said, noting medical technology often takes years to move from prototype to implementation.
She added: 'By the time I finish my PhD, three years from now, I'd love to see something well into the pipeline that's on its way to real-world use.'
The university said the long-term vision is to roll the system out first across remote regions of Scotland, before expanding to global areas with limited access to dermatological care.
It added the technology could also offer vital support to patients who are infirm or unable to travel, allowing loved ones to assist with capturing and submitting diagnostic images to GPs.
Ms Watt's academic supervisor, Dr Christos Chrysoulas, said: 'E-health devices must be engineered to operate independently of external connectivity to ensure continuity of patient service and safety.
'In the event of a network or cloud service failure, such devices must fail safely and maintain all essential clinical operations without functional degradation.
'While auxiliary or non-critical features may become temporarily unavailable, the core diagnostic and even therapeutic capabilities must remain fully operational, in compliance of course with safety and regulatory requirements.
'Ensuring this level of resilience in affordable, low-cost medical devices is the essence of our research, particularly for deployment in resource-limited settings and areas with limited or no connectivity, where uninterrupted patient care must still be guaranteed.'
UK Science and Technology Secretary Peter Kyle commented on the research, saying: 'Low-cost technology which could help detect skin cancer early and at home, without even the need for internet access, is an incredible example of AI's potential to break down barriers in healthcare and save lives.
'Promising, first of its kind research like this also demonstrates the crucial role UK innovators can play in improving the lives of people of all backgrounds, wherever they live, and makes clear the value of government investing in research to deliver our plan for change.'
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Scottish Government misses key skin cancer quality targets
Scottish Government misses key skin cancer quality targets

The Herald Scotland

time2 days ago

  • The Herald Scotland

Scottish Government misses key skin cancer quality targets

A total of 10 of 15 Quality Performance Indicators (QPIs) were met in the last year, with persistent challenges in meeting targets related to pathology, imaging and systemic therapy, according to the latest Public Health Scotland data. The data also shows that the limited availability of pathology services and operating theatres in Scotland is causing delays in diagnosing and treating skin cancer. READ MORE: NHS 'dying before our eyes' as third of Scots go private NHS Scotland: 'neurological patients falling through cracks' NHS Scotland: Nearly £2 billion spent on temp nurses and midwives The quality performance indicator target 7 - which deals with pathology and theatre capacity - remains difficult to achieve, as regional reports highlight limited pathology service capacity and operating theatre availability as key barriers to meeting these standards. Performance on imaging scans for patients with melanoma has also declined and has fallen short of national targets. According to Public Health Scotland, this target worsened in 2023-2024 after some improvement in the previous year. The Scottish Conservatives have criticised the government for "shameful delays" to skin cancer treatment which puts "lives at risk". Scottish Conservative shadow health secretary Dr Sandesh Gulhane MSP said: 'Under the SNP, far too many patients are not being diagnosed and treated in time for skin cancer. 'We know that these shameful delays harm a patients chance of recovery and puts lives at risk. 'The SNP's failure to improve cancer services has led to a shortage of vital pathology support and operating theatre access, while performance on melanoma imaging scans continues to decline. 'With Scotland recently enjoying a heatwave and many people enjoying the sun, it was a timely reminder of the dangers of skin cancer — and the critical need for rapid, effective treatment. 'That's why the Scottish Conservatives have set out common-sense proposals to prioritise early detection, promote healthy lifestyles and guarantee cancer services will have the resources they need to support patients.' Most skin cancers are caused by exposure to the sun and, in May, new data published by the charity Melanoma Focus showed 45% of Scottish people suffer from sunburn at least once every year. There are around 17,500 new melanoma skin cancer cases in the UK every year and it is the sixth most common cancer in Scotland. Melanoma is considered the most serious form of skin cancer because it has the highest mortality rate, and deaths from melanoma are projected to continue to rise. The Scottish Government are committing £14 million for NHS Health Boards to improve cancer waiting times and £21 million targeted towards imaging. Ministers have said this is in addition to an increase in funding to address pressures within chemotherapy services, reaching up to £10 million annually by 2027, with £6.6 million released in 2025/26. Health Secretary Neil Gray said: 'Whilst we are treating more patients with cancer on time, within both standards, compared to the same quarter 6 years ago, it is vital we do more to reduce cancer waiting times, especially for those cancers which are more aggressive. 'As we see an increasing number of eligible cancer referrals, that means we also see an increase in demand for diagnostics. That is why we have committed to a range of actions to tackle waits. This includes expanding to seven-day radiology services, increasing recruitment of staff, using mobile scanning units and reducing radiology backlogs so that 95% of referrals are seen within six weeks by March 2026."

Mum who blames mesh implant for crippling pain blasts Government for continued use
Mum who blames mesh implant for crippling pain blasts Government for continued use

Daily Record

time3 days ago

  • Daily Record

Mum who blames mesh implant for crippling pain blasts Government for continued use

Mum who blames mesh implant for crippling pain blasts Government for continued use Roseanna Clarkin is one of a number of women who blame mesh products for life-changing complications. Roseanna Clarkin; Surgical Mesh campaigner from Clydebank. A mum who blames a controversial plastic implant for her crippling pain has blasted the Scottish Government for continuing to use the products. ‌ Roseanna Clarkin is one of a number of women who blame mesh products for life-changing complications. ‌ In her case, it was used to treat an umbilical hernia in 2015. ‌ Roseanna Clarkin said: 'Vaginal mesh is banned but mesh is still used for other procedures. Ultimately it's the same mesh. There has to be an alternative.' Three years later, while the Scottish Government banned the use of trans vaginal mesh products, surgical mesh is still used for other procedures. Studies suggest five to 20 per cent of hernia operations result in mesh failure. A study in the British Medical Journal, said the rate could be 12 to 30 per cent. ‌ Campaigners have been calling for an independent review and patients including Roseanna want a ban on all surgical mesh and fixation devices. Roseanna, 41, of Clydebank, said: 'Vaginal mesh is banned but mesh is still used for other procedures. Ultimately, it's the same mesh that can cause the same problems.' Health Secretary Humza Yousaf has refused campaigners' call for an independent review into the use of mesh in all surgical procedures ‌ In 2023, then First Minister Humza Yousaf said to suspend the use of hernia mesh would leave some people with limited or no treatment options. Last year, Roseanna was diagnosed with a rectocele – a prolapse of the wall between the rectum and vagina – but was shocked doctors wanted to use mesh. She said: 'I was outraged. Mesh has caused ­devastating effects to my life and body. There was no way I was having any more.' From the late 90s to 2018, women in Scotland were treated with polypropylene mesh implants for stress urinary incontinence and pelvic organ prolapse. ‌ For some, it caused pain and life-changing side-effects. Affected patients can travel to England and the US for mesh removal surgery, funded by NHS Scotland and Scottish Government. Campaign group Sling the Mesh accused governments of 'dragging their feet' five years after the review. The group's Kath Sansom said: 'Traditional surgical repairs without mesh, and high-quality pelvic floor physiotherapy, should always be the first line of treatment for bladder leaks, prolapse and some bowel conditions.' The Scottish Government said it takes the concerns raised seriously and commissioned two reviews of hernia mesh use. Article continues below It added the reviews 'recommended the continued availability of surgical mesh as an option for repair of hernias, while stressing the importance of informed consent and the availability of alternative treatments where appropriate'. Don't miss the latest news from around Scotland and beyond - Sign up to our daily newsletter here.

East Kilbride business wins NHS Scotland contract for 'life-changing' stoma care product
East Kilbride business wins NHS Scotland contract for 'life-changing' stoma care product

Daily Record

time4 days ago

  • Daily Record

East Kilbride business wins NHS Scotland contract for 'life-changing' stoma care product

The discrete and easy-to-use stoma bag accompaniment is designed to contain leakage and reduce worry and discomfort. A vital NHS Scotland contract has been secured by a Lanarkshire business for its 'life-changing' stoma bag product. ‌ Confidence Plus was founded in East Kilbride in 2019 by Anne Inch and Lisa Crombie, who created ConfiPlus Stoma Pockets, with support from Business Gateway. ‌ The discrete and easy-to-use stoma bag accompaniment is designed to contain leakage and reduce worry and discomfort. Suitable for use with most stoma bags, the product helps minimise both the physical and mental impact of stoma care. ‌ By improving comfort, security and dignity, ConfiPlus Stoma Pockets empower users to regain their independence and enjoy greater freedom in everyday life. Download the Lanarkshire Live app today The Lanarkshire Live app is available to download now. Get all the news from your area – as well as features, entertainment, sport and the latest on Lanarkshire's recovery from the coronavirus pandemic – straight to your fingertips, 24/7. The free download features the latest breaking news and exclusive stories, and allows you to customise your page to the sections that matter most to you. Head to the App Store and never miss a beat in Lanarkshire - iOS - Android The product was created by ostomate (a person who has undergone ostomy surgery), Anne Inch, for her late husband Iain, who had an Ileostomy (the surgical procedure that creates a stoma) and suffered from constant leakage during frequent stays in the hospital. ‌ Anne wanted to find a new way to contain leakage and reduce the impact of the stoma. The first version was made on her sewing machine and she then went on to make more for other patients in her husband's ward after being encouraged by the nurses who saw the impact it had on Iain. ‌ The product first went on sale in the UK in December 2020 and are now made by a medical device manufacturer in Britain, and the team has had support from the Medical Device Manufacturing Centre working in partnership Heriot Watt University and the University of Dundee. At an early stage in 2019, Anne contacted her former colleague Lisa to ask about getting involved when she started Confidence Plus and Lisa was happy to support. They've been working together to build the business since then. With just 48 hours to prepare a high-stakes NHS Scotland tender for Stoma Supplies, Lisa turned to Business Gateway for urgent support. ‌ Adviser Debbie Dawkins provided intensive one-to-one guidance and quickly introduced the team to a procurement expert. A two-hour procurement session with consultant Judith Stewart helped improve the bid and ensure it met the robust NHS procurement standards. Lisa Crombie, co-founder of Confidence Plus Ltd, said: 'When I say I couldn't have done this without Debbie's help, I mean it. She went above and beyond, and we're so grateful for her support and the introductions she made to Judith and Zoe. ‌ "After speaking with Judith, I realised how far off the mark we were. Without her guidance, our tender simply wouldn't have met NHS Scotland's requirements. This success has been game-changing, not just for the business, but for the people we aim to support through ConfiPlus.' To comply with strict sustainability requirements, Anne and Lisa also accessed three days of Net Zero consultancy support through Business Gateway and developed a Carbon Management Plan, Environmental Policy and Carbon Management Policy demonstrating Confidence Plus's commitment to sustainability and responsible innovation. ConfiPlus won the NHS Scotland contract, bringing the product one step closer to helping thousands of stoma users across the UK. ‌ With continued support from Business Gateway and other partners, Confidence Plus is now exploring further opportunities to scale and bring its life-changing products to more stoma users across the UK and beyond. The pair have recently launched the business in the US to help stoma patients there too. Debbie Dawkins, Business Gateway adviser, said: 'Anne and Lisa's determination to get ConfiPlus into the hands of the people who need it most is incredibly inspiring. It's been a pleasure to support her through this critical process. Winning the NHS Scotland contract is a huge milestone, and I'm excited to see how the business continues to grow.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store